[Form 4] Chemours Co Insider Trading Activity

Rhea-AI Filing Summary

Chemours director Satterthwaite Livingston received 966 deferred stock units on 09/30/2025, each equal to one share of Chemours common stock and recorded at an acquisition price of $15.84 per unit. After the transaction the reporting person beneficially owns 3,280.0507 shares (direct). The deferred stock units become payable beginning the second calendar year after the reporting person ceases service as a director, so these units represent compensation that vests for payout on termination rather than immediate cash or share delivery. The Form 4 was signed by an attorney-in-fact on 10/02/2025 and identifies the reporting person as a director of Chemours (ticker: CC).

Positive

• Transparency: The Form 4 discloses the number of deferred stock units, acquisition date, and price ($15.84), providing clear record of insider holdings.
• Alignment with shareholders: Deferred stock units tie director compensation to share value and are payable after service ends, aligning long-term interests.

Negative

• None.

Insights

Financial Analyst

TL;DR: Routine director compensation recorded as 966 deferred stock units; modest change in beneficial ownership.

Receipts of 966 deferred stock units at $15.84 each are typical non-cash director compensation that increase reported beneficial ownership to 3,280.0507 shares. This transaction does not show an immediate cash sale or purchase of common stock and represents deferred equity exposure tied to future termination timing. For investors, the item is informative about director compensation structure but is not a material change to capital structure based solely on the numbers reported.

Corporate Governance Expert

TL;DR: Standard deferred equity grant for a director; payout contingent on post-termination timing.

The filing documents a deferred stock unit award where each unit equals one share and becomes payable beginning in the second calendar year after the director leaves service. That design is consistent with deferred compensation practices intended to align long-term interests without immediate dilution. The Form 4 clearly states the nature and payout timing, providing transparency on insider holdings and compensation timing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

SATTERTHWAITE LIVINGSTON

(Last) (First) (Middle)

C/O THE CHEMOURS COMPANY

1007 MARKET STREET

(Street)

WILMINGTON DE 19801

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Chemours Co [ CC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	09/30/2025		A		966		(1)	(1)	Common Stock	966	$15.84	3,280.0507	D

Explanation of Responses:

1. Each deferred stock unit is the economic equivalent of one share of the Issuer's common stock. The deferred stock units become payable upon the second calendar year following the Reporting Person's termination of service as a director.

	/s/ Eric Stein, Attorney-in-Fact	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Chemours director Satterthwaite Livingston acquire on 09/30/2025?

The reporting person received 966 deferred stock units, each equivalent to one share of Chemours common stock.

How many shares does Livingston beneficially own after the reported transaction?

Following the transaction the reporting person beneficially owns 3,280.0507 shares (direct).

When are the deferred stock units payable?

The deferred stock units become payable beginning the second calendar year after the reporting person’s termination of service as a director.

What price is recorded for the deferred stock units on the Form 4?

The Form 4 lists a price of $15.84 per deferred stock unit.

Who signed the Form 4 and when?

The Form 4 was signed by Eric Stein, Attorney-in-Fact on 10/02/2025.